ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1111

Impact of Bariatric Surgery on Kidney Function: A Prospective Analysis of Short-Term Outcomes

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Claure-Del Granado, Rolando, Universidad Mayor de San Simon, Cochabamba, Bolivia, Plurinational State of
  • Carlos-Rodríguez, Verónica N., Universidad Mayor de San Simon, Cochabamba, Bolivia, Plurinational State of
  • Aparicio-Yuja, Sergio O., Universidad Mayor de San Simon, Cochabamba, Bolivia, Plurinational State of
Background

Obesity and diabetes mellitus are leading causes of chronic kidney disease . Patients with obesity are more likely to develop chronic kidney disease and end-stage kidney failure. In the long-term, individuals with a body mass index (BMI) greater than 30 kg/m2 have a significant higher risk of glomerular filtration rate decline. This study investigated the effects of bariatric surgery on estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR) in morbidly obese patients.

Methods

Clinical variables for patients who underwent bariatric surgery were prospectively analyzed over a 12-month follow-up period between January 15, 2021, and August 14, 2023. eGFR (ml/min/1.73m2) was calculated using the serum creatinine CKD-EPI formula. Urinary ACR was measured during the follow-up. Body mass index (BMI, kg/m2), percent weight loss (%WL), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were recorded during the follow-up.

Results

Eighty-two patients were included, 48,8% (n=40) underwent bariatric surgery-laparoscopic Roux-en-Y gastric bypass (LRYGB), 39% (n=32) underwent laparoscopic sleeve gastrectomy (LSG; n = 39) and 12,2% (n=10) underwent intestinal bipartition. Baseline characteristics and follow-up parameters are presented in Table 1. The eGFR of both groups increased at the follow-up outpatient visits (months 1, 3 and 12) (p < 0.001) as shown in Table 1. The ACR decreased in the first month and twelve months after the bariatric surgery (p < 0.0001). The SBP and DBP decreased after bariatric surgery, with no significant difference between the three groups (p > 0.05).

Conclusion

Bariatric surgery is associated with improvements in postoperative renal function 1, 3 and 12 months following surgery, with significant reductions in ACR and better blood pressure control.

Table 1. Improvement in different parameters, blood pressure values, and eGFR after bariatric surgery